Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | GFER | P55789 | 1/20 | 0.53 |
| ▸ | ESR1 | P03372 | 2/20 | 0.43 |
| ▸ | SPHK2 | Q9NRA0 | 2/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.43 |
| ▸ | PGR | P06401 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3979935 | 0.88 | MEN1 (0.50) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL3982533 | 0.86 | MEN1 (0.48) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL4952041 | 0.85 | MEN1 (0.42) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL3974936 | 0.85 | MEN1 (0.47) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL3981040 | 0.84 | MEN1 (0.49) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL3972504 | 0.84 | MEN1 (0.46) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL18009643 | 0.83 | GRIN2D (0.47) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL3973937 | 0.83 | ESR1 (0.40) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL1972365 | 0.80 | MEN1 (0.79) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL3973988 | 0.80 | MEN1 (0.48) | MEN1KMT2APOLBGAAGFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1469026-B1 | AROMATIC POLYCARBONATE RESIN PROCESS FOR PRODUCING THE SAME OPTICAL PART MOLDING MATERIAL AND OPTICAL PART | IDEMITSU KOSAN CO (JP) | 2009-05-06 | — | — | EP | disclosed |
| US-7456323-B2 | 1,3-bis(3-formyl-4-hydroxyphenyl)adamantanes and polynuclear polyphenols derived therefrom | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2008-11-25 | — | — | US | disclosed |
| US-20080242896-A1 | 1,3-Bis(3-Formyl-4-Hydroxyphenyl)Adamantanes and Polynuclear Polyphenols Derived Therefrom | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2008-10-02 | — | — | US | disclosed |
| EP-1336597-B1 | Hydroxyphenyl adamantanes and process for the production of the same | HONSHU CHEMICAL IND (JP) | 2008-07-16 | — | — | EP | disclosed |
| US-7329718-B2 | Aromatic polycarbonate resin, process for producing the same, optical-part molding material, and optical part | IDEMITSU KOSAN CO., LTD. (JP) | 2008-02-12 | — | — | US | disclosed |
| US-20060270823-A1 | Suited to a molding material for an optical disc substrate such as a digital audio disc, a digital video disc and an optical memory disc, various lenses such as a lens for an optical pickup, spectacle lenses, contact lenses and a lens sheet, an optical sheet substrate | IDEMITSU KOSAN CO., LTD (JP) | 2006-11-30 | — | — | US | disclosed |
| US-7112644-B2 | Aromatic polycarbonate resin, process for producing the same, optical-part molding material, and optical part | IDEMITSU KOSAN CO., LTD. (JP) | 2006-09-26 | — | — | US | disclosed |
| US-20050143553-A1 | Aromatic polycarbonate resin, process for producing the same, optical-part molding material, and optical part | IDEMITSU KOSAN CO., LTD (JP) | 2005-06-30 | — | — | US | disclosed |
| EP-1469026-A1 | AROMATIC POLYCARBONATE RESIN PROCESS FOR PRODUCING THE SAME OPTICAL PART MOLDINGMATERIAL AND OPTICAL PART | IDEMITSU KOSAN CO., LTD. (JP) | 2004-10-20 | — | — | EP | disclosed |
| US-6720460-B2 | FORMING HEAT RESISTANT, MECHANICAL STRENGTH POLYMER ADDITIVES; ACID CATALYZED REACTION OF ADAMANTANE DIOL OR TRIOL WITH PHENOLIC DERIVATIVE | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2004-04-13 | — | — | US | disclosed |
| US-20030187307-A1 | Hydroxyphenyl adamantanes and process for the production of the same | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2003-10-02 | — | — | US | disclosed |
| EP-1336597-A1 | Hydroxyphenyl adamantanes and process for the production of the same | Honshu Chemical Industry Co., Ltd. (JP) | 2003-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030187307-A1 | Hydroxyphenyl adamantanes and process for the production of the same | CYP8B1, DHPS, P4HA1 | MEN1 1025/4885KMT2A 4019/4885POLB 727/4885 |
| US-20080242896-A1 | 1,3-Bis(3-Formyl-4-Hydroxyphenyl)Adamantanes and Polynuclear Polyphenols Derived Therefrom | HNMT, NEFM, CD69 | MEN1 4682/4885KMT2A 2847/4885POLB 457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.